Ionisations within a subtilisin-glyoxal inhibitor complex.
Z-Ala-Pro-Phe-glyoxal (where Z is benzyloxycarbonyl) has been shown to be a competitive inhibitor of subtilisin with a K(i)=2.3+/-0.2 microM at pH 7.0 and 25 degrees C. Using Z-Ala-Pro-[2-(13)C]Phe-glyoxal we have detected a signal at 107.3 ppm by (13)C NMR, which we assign to the tetrahedral adduct formed between the hydroxy group of serine-195 and the (13)C-enriched keto-carbon of the inhibitor. The chemical shift of this signal is pH independent from pH 4.2 to 7.0 and we conclude that the oxyanion pK(a)<3. This is the first observation of oxyanion formation in a reversible subtilisin-inhibitor complex. The inhibitor is bound as a hemiketal which is in slow exchange with the free inhibitor. Inhibitor binding depends on a pK(a) of approximately 6.5 in the free enzyme and on a pK(a)<3.0 when the inhibitor is bound to subtilisin. Protonation of the oxyanion promotes the disassociation of the inhibitor. We show that oxyanion formation cannot be rate limiting during catalysis and that subtilisin stabilises the oxyanion by at least 45.1 kJ mol(-1). We conclude that if the energy required for oxyanion stabilisation is utilised as binding energy in drug design it should make a significant contribution to inhibitor potency.
Djurdjevic-Pahl
Aleksandra
A
Centre for Synthesis and Chemical Biology, Conway Institute of Biomolecular and Biomedical Research, Department of Biochemistry, University College Dublin, Belfield, Dublin 4, Ireland.
Hewage
Chandralal
C
Malthouse
J Paul G
JP
D000838:Anions / Q000737:chemistry; D002384:Catalysis; D006037:Glyoxal / Q000031:analogs & derivatives* / Q000737:chemistry* / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D006868:Hydrolysis; D019906:Nuclear Magnetic Resonance, Biomolecular; D009842:Oligopeptides / Q000737:chemistry* / Q000494:pharmacology; D015842:Serine Proteinase Inhibitors / Q000737:chemistry* / Q000494:pharmacology; D020860:Subtilisin / Q000037:antagonists & inhibitors / Q000737:chemistry*
D000838:Anions; D009842:Oligopeptides; D015842:Serine Proteinase Inhibitors; C501834:Z-Ala-Pro-Phe-glyoxal; D006037:Glyoxal; C043307:succinyl-alanyl-alanyl-prolyl-phenylalanine-4-nitroanilide; D020860:Subtilisin